oncolytic HSV therapy (Immvira)

N/A

Report date: 2025/03/20 10:02:28

Base Information

Drug Nameoncolytic HSV therapy (Immvira)
Drug Alias Namerecombinant oHSV-1 construct (Immuno Vir)recombinant oHSV-1 construct (Immvira)recombinant oncolytic herpes simplex virus type 1 construct (Immuno Vir)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesImmvira Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmvira Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A